Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEV™ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in ...
The proposed Nasdaq listing is expected to be established as a Level II American Depositary Receipt (ADR) program, enabling streamlined and simplified access to Telix shares by the U.S. market. The ...
In my new paper published by the Aspen Economic Strategy Group, I highlight the persistence of unhealthy globalization and lay out some proposals for a more sustainable regime.